Facts and figures

Scientists at CAMH

Research rankings

Top media stories 2018

1. Half of female students in Ontario experience psychological distress, CAMH study shows
   (Results from the 2017 Ontario Student Drug Use and Health Survey)


2. What suicide notes teach us about experiences with mental illness and mental health care
   (Study published in the Canadian Journal of Psychiatry)


3. People with schizophrenia account for more than 1 in 10 suicide cases
   (Study published in the journal Schizophrenia Research)

Media mentions

Research expenditures

Publications and citations

Translating discoveries into treatment

App4Independence (A4i) is an app and web portal to support people with schizophrenia and psychosis, and is being developed in a joint venture between CAMH and MEMOTEXT Corporation. The mobile and web-based platform provides patient-informed tools, including medication and appointment reminders, evidence-based strategies to cope with symptoms, and peer-to-peer support. The platform will undergo broad user testing as the next step.

2018 MILESTONES

• Initial beta testing by users has been completed.
• A patent application was filed for the app’s auditory hallucination detector.

Dr. Jeffrey Meyer has developed a natural health product with a unique combination of ingredients that replenishes essential brain chemicals to boost mood after childbirth. This CAMH-developed formulation is safe for use by breastfeeding mothers, and is now being studied in a randomized controlled trial.

2018 MILESTONES

• A U.S. patent was issued
• A new company, Venessance Innovations Inc., was create
• A large market research survey was completed, with highly favourable results.